Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07115108

Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease

The purpose of this study is to compare the effect of high and ordinary energy density enteral nutrition for improving physical growth and brain cognitive development in infants with congenital heart disease after operation, as well as evaluate the safety of interventions.

Recruiting

Interested in participating?

Request Info

Key information

Age range

0 month–6 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

Location status: Recruiting

Location contact

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with congenital heart disease through symptoms, physical signs, imaging, and ultrasound examinations.
  • Age 0-6 months
  • Children with nutritional risks (defined by STRONGkids: Nutritional risk screening tool for children )
  • Artificial or mixed feeding
  • Open heart surgery under cardiopulmonary bypass
  • The guardians of the children voluntarily participate in this study and sign a written informed consent form before the surgery.

Exclusion criteria

  • Diagnosed with major non cardiac diseases leading to nutritional intake disorders, such as congenital gastrointestinal malformations, preoperative diagnosis of gastroesophageal reflux, genetic diseases related to growth restriction, and various syndromes with chromosomal abnormalities (trisomy 21 syndrome, trisomy 18 syndrome)
  • Abnormal immune system function due to congenital or acquired factors, unable to effectively resist pathogens or eliminate abnormal cells, which can be divided into primary and secondary immunodeficiencies.
  • Any pre - operative history of neurological diseases (e.g., encephalitis, epilepsy).
  • Secondary or primary gastrointestinal infection symptoms such as abdominal distension and diarrhea after surgery.
  • Estimated stay time in the postoperative intensive care unit ≤ 2 days

Treatment and study plan

High energy density enteral nutrition

Dietary Supplement

High-energy-density enteral nutrition (100 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.

Other names: High energy density EN

General energy density enteral nutrition

Dietary Supplement

General energy density enteral nutrition (60-88 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.

Other names: General energy density EN

Primary outcomes

  1. Weight-for-age z score (WAZ)

    Time frame: 6th month after discharge

    WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.

Secondary outcomes

  1. Weight-for-age z score (WAZ)

    Time frame: Before discharge, 1st month, 3rd month after discharge

    WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.

  2. Cognitive development

    Time frame: Before discharge, 1st month, 3rd month, 6th month after discharge

    The Griffiths mental development scales (GMDs) will be used to repeatedly measure the indicators .The Griffiths scales typically yield a Developmental Quotient (DQ) with an average range of 85-115. The higher the scores, the more advanced development relative to age norms in assessed domains (e.g., motor, language, or cognition).

  3. Incidence of subjects with Gastrointestinal mucosal barrier function injury

    Time frame: Before discharge, 1 month, 3 months, 6 months after discharge

    Primarily defined by elevation in fecal calprotectin and Inflammatory cytokines level.The reference range for calprotectin is 0-5 μg/g,inflammatory cytokines is ≤20pg/ml.Exceeding this range will be considered as abnormal gastrointestinal mucosal barrier function.

  4. Albumin level

    Time frame: Before discharge, 1 month, 3 months, 6 months after discharge

    Albumin is a rich protein in the blood, which mainly reflects the nutritional status.The reference range for albumin is 39-54g/L.If it is not within this range, it will be judged as abnormal.

  5. Blood lipid levels

    Time frame: Before discharge, 1 month, 3 months, 6 months after discharge

    Blood lipid test is to measure the content of lipids in blood.Blood lipids include total cholesterol(0-5.18mmol/L) and triglycerides(0-1.7mmol/L).If it exceeds the range, it will be considered as abnormal.

  6. Energy intake (cal/d)

    Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge

    Calculate the caloric intake for enteral feeding according to the Schofeld formula recommended by the European Society for Pediatric and Neonatal Intensive Care (ESPNIC)

  7. Enteral Nutrition intake (ml/d)

    Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge

    Based on the child's weight and the fluid balance in the previous 24 hours, the total fluid intake for the day is calculated. After subtracting the amount of intravenous drug solution, the amount of enteral nutrition formula is obtained. According to the child's gastrointestinal function, the principle of gradual progress is adopted to rationally allocate the single feeding volume and feeding frequency.

  8. Incidence of malabsorption

    Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge

    Incidence of malabsorption (as defined by any of the following criteria): abnormal fecal lactose content; abnormal fecal fat content.The diagnosis will be confirmed by fecal examination.

  9. Incidence of feeding intolerance

    Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge

    Any of the following condition: 1. Frequent vomiting (≥ 3 times/d); 2.Abdominal distension; 3. Milk volume did not increase or decreased>3 d; 4. Gastric retention (retention>1/3 of the previous feeding); 5. Unplanned discontinuation of feeding ≥ 2 times; 6. Diarrhea (stool frequency>6 times/d)

  10. Incidence of necrotizing enterocolitis(NEC)

    Time frame: Before discharge, 1 month, 3 months, 6 months after discharge

    NEC diagnosed in stage II and III will be recorded.

  11. Other surgical indications

    Time frame: At the day of discharge, an average of 3 week after surgery

    Mechanical ventilation time (days), postoperative CCU hospitalization duration (days), total hospitalization duration (days), hospitalization costs (Yuan), and the incidence of poor wound healing will be recorded.

Study contacts

Contact information is provided by the study sponsor or research team.

Sponsors and collaborators

Lead sponsor

Children's Hospital of Fudan University

Other

Registry information

Official study title

Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease: A Randomized Controlled Study

Acronym: RCT

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 11, 2025
Registry last updated
May 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.